Skip to main content
SpringerLink
Log in

How COVID-19 Has Globalized: Unknown Origin, Rapid Transmission, and the Immune System Nourishment

  • Chapter
  • First Online:
Coronavirus Disease - COVID-19

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1318))

Abstract

The novel coronavirus disease (COVID-19) profoundly influences T-cell immunity. The counts of total T cells and T-cell subsets, especially CD4+ and CD8+ T cells, are decreased in patients with COVID-19. Also, the function of these cells becomes less effective as the expression of immune inhibitory receptors, such as Tim3 and PD-1, increases over time during the disease. Kinetic analyses show that the T-cell profile changes dynamically, so does the COVID-19 stages. As COVID-19 continues to deteriorate and progresses to severe/critical condition, the lymphocyte count steadily decreases. Therefore, the ability of COVID-19 to escape the immune system might lie in its power to profoundly diminish T-cell effective function, which is necessary for the establishment of a robust antiviral immunity. Also, COVID-19 is associated with increased numbers of monocytes and macrophages, and as the disease progresses from a mild form to a severe/critical condition, the macrophage population becomes denser. Monitoring the expression of cytokines associated with macrophage activation, mainly interleukin (IL)-6 and IL-10, indicates that the course of COVID-19 consists of two stages and the transition between disease stages occurs by the end of the first week after onset of symptoms. At the initial stage, the immune military recognizes the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as nonself and thus fires macrophages at the lungs against the virus. The first flame can control disease progression effectively. However, a trained immunocompetent system would maintain the fire of macrophages over an extended time. It lies in its immune memory in tissue-resident macrophages, especially alveolar macrophages, making a professionally trained immune system more likely to be feared by COVID-19 than an untrained immune system. In this manner, the trained immunocompetent system commits such a failure that causes the lungs to come down rapidly. The fact that younger age groups, including neonates and children, are less susceptible to COVID-19 than older age groups reflects that the natural affinities of the immune system that has not been trained thoroughly would be standard in combatting against COVID-19 whereas the higher affinities of the trained immune system for rapid activation of immune responses might raise faults – the lungs come down.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Ahanchian H, Moazzen N, Faroughi MSD, Khalighi N, Khoshkhui M, Aelami MH, Haghi NSM, Rezaei N (2020) COVID-19 in a child with primary specific antibody deficiency

    Google Scholar 

  • Ahmadi M, Saffarzadeh N, Habibi MA, Hajiesmaeili F, Rezaei N (2020) Colon cancer and SARS-CoV-2: impact of ACE2 expression in susceptibility to COVID-19. bioRxiv

    Google Scholar 

  • Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW (1997) Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 38(1):36–47

    CAS  PubMed  Google Scholar 

  • Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF (2020) The proximal origin of SARS-CoV-2. ARTIC Network 17

    Google Scholar 

  • Babaha F, Rezaei N (2020) Primary immunodeficiency diseases in COVID-19 pandemic: a predisposing or protective factor? Am J Med Sci. https://doi.org/10.1016/j.amjms.2020.07.027

  • Bahrami A, Vafapour M, Moazzami B, Rezaei N (2020) Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: first case from Iran. J Paediatr Child Health. https://doi.org/10.1111/jpc.15048

  • Basiri A, Heidari A, Nadi MF, Fallahy MTP, Nezamabadi SS, Sedighi M, Saghazadeh A, Rezaei N (2020a) Microfluidic devices for detection of RNA viruses. Reviews in Medical Virology n/a (n/a):e2154. https://doi.org/10.1002/rmv.2154

  • Basiri A, Pazhouhnia Z, Beheshtizadeh N, Hoseinpour M, Saghazadeh A, Rezaei N (2020b) Regenerative medicine in COVID-19 treatment: real opportunities and range of promises. Stem Cell Rev Rep:1–13. https://doi.org/10.1007/s12015-020-09994-5

  • Bonilla-Aldana DK, Cardona-Trujillo MC, García-Barco A, Holguin-Rivera Y, Cortes-Bonilla I, Bedoya-Arias HA, Patiño-Cadavid LJ, Paniz-Mondolfi A, Zambrano LI, Dhama K (2020) MERS-CoV and SARS-CoV infections in animals: a systematic review and meta-analysis of prevalence studies

    Google Scholar 

  • Brodsky IE, Medzhitov R (2011) Pyroptosis: macrophage suicide exposes hidden invaders. Curr Biol 21(2):R72–R75

    Article  CAS  Google Scholar 

  • Cai Y, Hao Z, Gao Y, Ping W, Wang Q, Peng S, Zhao B, Sun W, Zhu M, Li K (2020) Clinical characteristics of seven cases infected with SARS-CoV-2 in the perioperative period of lung resection: a retrospective study from a single thoracic Department in Wuhan, China

    Google Scholar 

  • Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y (2020a) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513

    Article  CAS  Google Scholar 

  • Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, Men D, Huang Q, Liu Y, Yang B (2020b) Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely associated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients. medRxiv

    Google Scholar 

  • Darbeheshti F, Rezaei N (2020) Genetic predisposition models to COVID-19 infection. Med Hypotheses 142:109818. https://doi.org/10.1016/j.mehy.2020.109818

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, Chen L, Li M, Liu Y, Wang G (2020) Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19). medRxiv

    Google Scholar 

  • Doitsh G, Galloway NLK, Geng X, Yang Z, Monroe KM, Zepeda O, Hunt PW, Hatano H, Sowinski S, Muñoz-Arias I (2014) Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 505(7484):509–514

    Article  CAS  Google Scholar 

  • Fathi N, Rezaei N (2020) Lymphopenia in COVID-19: therapeutic opportunities. Cell Biol Int 44(9):1792–1797. https://doi.org/10.1002/cbin.11403

    Article  CAS  PubMed  Google Scholar 

  • Franks TJ, Chong PY, Chui P, Galvin JR, Lourens RM, Reid AH, Selbs E, McEvoy CPL, Hayden CDL, Fukuoka J (2003) Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum Pathol 34(8):743–748

    Article  Google Scholar 

  • Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, Liu L, Shan H, Lei C-I, Hui DSC (2020) Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med

    Google Scholar 

  • Hanaei S, Rezaei N (2020) COVID-19: developing from an outbreak to a pandemic. Arch Med Res. https://doi.org/10.1016/j.arcmed.2020.04.021

  • Horton R (2020) Offline: COVID-19 and the NHS-“a national scandal”. Lancet 395(10229):1022. https://doi.org/10.1016/S0140-6736(20)30727-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jabbari P, Rezaei N (2020) With risk of reinfection, is COVID-19 here to stay? Disaster Med Public Health Prep:1. https://doi.org/10.1017/dmp.2020.274

  • Jabbari P, Jabbari F, Ebrahimi S, Rezaei N (2020) COVID-19: a chimera of two pandemics. Disaster Med Public Health Prep:1–2. https://doi.org/10.1017/dmp.2020.223

  • Jahanshahlu L, Rezaei N (2020a) Central nervous system involvement in COVID-19. Arch Med Res. https://doi.org/10.1016/j.arcmed.2020.05.016

  • Jahanshahlu L, Rezaei N (2020b) Monoclonal antibody as a potential anti-COVID-19. Biomed Pharmacother 129:110337. https://doi.org/10.1016/j.biopha.2020.110337

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ji W, Wang W, Zhao X, Zai J, Li X (2020) Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human. J Med Virol

    Google Scholar 

  • Jiang Y, Li J, Teng Y, Sun H, Tian G, He L, Li P, Chen Y, Guo Y, Li J (2019) Complement receptor C5aR1 inhibition reduces pyroptosis in hDPP4-transgenic mice infected with MERS-CoV. Viruses 11(1):39

    Article  CAS  Google Scholar 

  • Jiang W, Zeng Z, Fan D, Zhang Y, Chen Z, Jiang W, Xie S, Xia H, Jiang Y-A, Liu X-A (2020) Decreased counts of T lymphocyte subsets predict prognosis in SARS-CoV-2-infected pneumonia in Wuhan, China: A Retrospective Study (February 20, 2020)

    Google Scholar 

  • Kacprzyk J, Hughes GM, Palsson-McDermott EM, Quinn SR, Puechmaille SJ, O’Neill LAJ, Teeling EC (2017) A potent anti-inflammatory response in bat macrophages may be linked to extended longevity and viral tolerance. Acta Chiropterologica 19(2):219–228

    Article  Google Scholar 

  • Kafieh R, Arian R, Saeedizadeh N, Minaee S, Yadav SK, Vaezi A, Rezaei N, Javanmard SH (2020) COVID-19 in Iran: a deeper look into the future. medRxiv

    Google Scholar 

  • Keidar S, Strizevsky A, Raz A, Gamliel-Lazarovich A (2007) ACE2 activity is increased in monocyte-derived macrophages from prehypertensive subjects. Nephrol Dial Transplant 22(2):597–601

    Article  CAS  Google Scholar 

  • Kucharski AJ, Russell TW, Diamond C, Liu Y, Edmunds J, Funk S, Eggo RM, Sun F, Jit M, Munday JD (2020) Early dynamics of transmission and control of COVID-19: a mathematical modelling study. Lancet Infect Dis

    Google Scholar 

  • Legido-Quigley H, Mateos-García JT, Campos VR, Gea-Sánchez M, Muntaner C, McKee M (2020) The resilience of the Spanish health system against the COVID-19 pandemic. The Lancet Public Health

    Google Scholar 

  • Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, Wang H, Crameri G, Hu Z, Zhang H (2005) Bats are natural reservoirs of SARS-like coronaviruses. Science 310(5748):676–679

    Article  CAS  Google Scholar 

  • Li B, Feng F, Yang G, Liu A, Yang N, Jiang Q, Zhang H, Wang T, Li P, Mao Y (2020a) Immunoglobulin G/M and cytokines detections in continuous sera from patients with novel coronaviruses (2019-nCoV) infection. Available at SSRN 3543609

    Google Scholar 

  • Li L, Li S, Xu M, Zheng S, Duan Z, Chen Y, Li J (2020b) The level of plasma C-reactive protein is closely related to the liver injury in patients with COVID-19. medRxiv

    Google Scholar 

  • Liao M, Liu Y, Yuan J, Wen Y, Xu G, Zhao J, Chen L, Li J, Wang X, Wang F (2020) The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing. medRxiv

    Google Scholar 

  • Liu J, Li S, Liu J, Liang B, Wang X, Li W, Wang H, Tong Q, Yi J, Zhao L (2020) Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients

    Google Scholar 

  • Lotfi M, Rezaei N (2020) SARS-CoV-2: a comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol. https://doi.org/10.1002/jmv.26123

  • Lotfi M, Hamblin MR, Rezaei N (2020) COVID-19: transmission, prevention, and potential therapeutic opportunities. Clinica Chimica Acta 508:254–266. https://doi.org/10.1016/j.cca.2020.05.044

    Article  CAS  Google Scholar 

  • Luo W, Yu H, Gou J, Li X, Sun Y, Li J, Liu L (2020) Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19)

    Google Scholar 

  • Mansourabadi AH, Sadeghalvad M, Mohammadi-Motlagh HR, Rezaei N (2020) The immune system as a target for therapy of SARS-CoV-2: a systematic review of the current immunotherapies for COVID-19. Life Sci 258:118185. https://doi.org/10.1016/j.lfs.2020.118185

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Menachery VD, Yount BL Jr, Debbink K, Agnihothram S, Gralinski LE, Plante JA, Graham RL, Scobey T, Ge X-Y, Donaldson EF (2015) A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat Med 21(12):1508

    Article  CAS  Google Scholar 

  • Millán-Oñate J, Rodriguez-Morales AJ, Camacho-Moreno G, Mendoza-Ramírez H, Rodríguez-Sabogal IA, Álvarez-Moreno C (2020) A new emerging zoonotic virus of concern: the 2019 novel coronavirus (COVID-19). Infection 24(3)

    Google Scholar 

  • Mirbeyk M, Rezaei N (2020) The impact of COVID-19 on pregnancy and neonatal health: a systematic review

    Google Scholar 

  • Moazzami B, Razavi-Khorasani N, Dooghaie Moghadam A, Farokhi E, Rezaei N (2020) COVID-19 and telemedicine: immediate action required for maintaining healthcare providers well-being. J Clin Virol 126:104345. https://doi.org/10.1016/j.jcv.2020.104345

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mohamed K, Rodríguez-Román E, Rahmani F, Zhang H, Ivanovska M, Makka SA, Joya M, Makuku R, Islam MS, Radwan N, Rahmah L, Goda R, Abarikwu SO, Shaw M, Zoghi S, Irtsyan S, Ling I, Cseprekal O, Faten AB, Hazar Sayar E, Soloukey C, Grancini G, Rezaei N (2020a) Borderless collaboration is needed for COVID-19-A disease that knows no borders. Infect Control Hosp Epidemiol:1–2. https://doi.org/10.1017/ice.2020.162

  • Mohamed K, Yazdanpanah N, Saghazadeh A, Rezaei N (2020b) Computational drug discovery and repurposing for the treatment of Covid-19: a systematic review. Available at SSRN 3583748

    Google Scholar 

  • Momtazmanesh S, Ochs HD, Uddin LQ, Perc M, Routes JM, Vieira DN, Al-Herz W, Baris S, Prando C, Rosivall L, Abdul Latiff AH, Ulrichs T, Roudenok V, Aldave Becerra JC, Salunke DB, Goudouris E, Condino-Neto A, Stashchak A, Kryvenko O, Stashchak M, Bondarenko A, Rezaei N (2020) All together to fight COVID-19. Am J Trop Med Hyg 102(6):1181–1183. https://doi.org/10.4269/ajtmh.20-0281

    Article  PubMed  PubMed Central  Google Scholar 

  • Moradian N, Ochs HD, Sedikies C, Hamblin MR, Camargo CA Jr, Martinez JA, Biamonte JD, Abdollahi M, Torres PJ, Nieto JJ, Ogino S, Seymour JF, Abraham A, Cauda V, Gupta S, Ramakrishna S, Sellke FW, Sorooshian A, Wallace Hayes A, Martinez-Urbistondo M, Gupta M, Azadbakht L, Esmaillzadeh A, Kelishadi R, Esteghamati A, Emam-Djomeh Z, Majdzadeh R, Palit P, Badali H, Rao I, Saboury AA, Jagan Mohan Rao L, Ahmadieh H, Montazeri A, Fadini GP, Pauly D, Thomas S, Moosavi-Movahed AA, Aghamohammadi A, Behmanesh M, Rahimi-Movaghar V, Ghavami S, Mehran R, Uddin LQ, Von Herrath M, Mobasher B, Rezaei N (2020) The urgent need for integrated science to fight COVID-19 pandemic and beyond. J Transl Med 18(1):205. https://doi.org/10.1186/s12967-020-02364-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Munster V, Feldmann F, Williamson B, Van Doremalen N, Perez-Perez L, Schultz J, Meade-White K, Okumura A, Callison J, Brumbaugh B (2020) Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2. BioRxiv

    Google Scholar 

  • Nasab MG, Saghazadeh A, Rezaei N (2020) SARS-CoV-2-A tough opponent for the immune system. Arch Med Res. https://doi.org/10.1016/j.arcmed.2020.05.020

  • Nicholls JM, Poon LLM, Lee KC, Ng WF, Lai ST, Leung CY, Chu CM, Hui PK, Mak KL, Lim W (2003) Lung pathology of fatal severe acute respiratory syndrome. Lancet 361(9371):1773–1778

    Article  Google Scholar 

  • Pashaei M, Rezaei N (2020) Immunotherapy for SARS-CoV-2: potential opportunities. Expert Opin Biol Ther:1–5. https://doi.org/10.1080/14712598.2020.1807933

  • Pourahmad R, Moazzami B, Rezaei N (2020) Efficacy of plasmapheresis and immunoglobulin replacement therapy (IVIG) on patients with COVID-19. SN Comprehensive Clin Med:1–5

    Google Scholar 

  • Rabiee N, Rabiee M, Bagherzadeh M, Rezaei N (2020) COVID-19 and picotechnology: potential opportunities. Med Hypotheses 144:109917. https://doi.org/10.1016/j.mehy.2020.109917

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rezaei N (2020a) COVID-19 affects healthy pediatricians more than pediatric patients. Infect Control Hosp Epidemiol 1. https://doi.org/10.1017/ice.2020.139

  • Rezaei N (2020b) COVID-19 and medical biotechnology. Avicenna J Med Biotechnol 12(3):139

    PubMed  PubMed Central  Google Scholar 

  • Rokni M, Hamblin MR, Rezaei N (2020) Cytokines and COVID-19: friends or foes? Human Vaccines & Immunotherapeutics:1–3

    Google Scholar 

  • Rzymski P, Nowicki M, Mullin GE, Abraham A, Rodríguez-Román E, Petzold MB, Bendau A, Sahu KK, Ather A, Naviaux A-F (2020) Quantity does not equal quality: scientific principles cannot be sacrificed. Int Immunopharmacol 86:106711

    Article  CAS  Google Scholar 

  • Saghazadeh A, Rezaei N (2020a) Immune-epidemiological parameters of the novel coronavirus - a perspective. Expert Rev Clin Immunol 16(5):465–470. https://doi.org/10.1080/1744666x.2020.1750954

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Saghazadeh A, Rezaei N (2020b) Towards treatment planning of COVID-19: rationale and hypothesis for the use of multiple immunosuppressive agents: anti-antibodies, immunoglobulins, and corticosteroids. Int Immunopharmacol 84:106560. https://doi.org/10.1016/j.intimp.2020.106560

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sahu KK, Siddiqui AD, Rezaei N, Cerny J (2020) Challenges for management of immune thrombocytopenia during COVID-19 pandemic. J Med Virol. https://doi.org/10.1002/jmv.26251

  • Saleki K, Banazadeh M, Saghazadeh A, Rezaei N (2020) The involvement of the central nervous system in patients with COVID-19. Rev Neurosci 31(4):453–456. https://doi.org/10.1515/revneuro-2020-0026

    Article  CAS  PubMed  Google Scholar 

  • Shamshirian D, Rezaei N (2020) Cardiovascular diseases burden in COVID-19: systematic review and meta-analysis

    Google Scholar 

  • Sharifkashani S, Bafrani MA, Khaboushan AS, Pirzadeh M, Kheirandish A, Yavarpour Bali H, Hessami A, Saghazadeh A, Rezaei N (2020) Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: potential therapeutic targeting. Eur J Pharmacol 884:173455. https://doi.org/10.1016/j.ejphar.2020.173455

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shi C-S, Nabar NR, Huang N-N, Kehrl JH (2019) SARS-coronavirus open reading frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes. Cell Death Dis 5(1):1–12

    Google Scholar 

  • Shimabukuro-Vornhagen A, Gödel P, Subklewe M, Stemmler HJ, Schlößer HA, Schlaak M, Kochanek M, Böll B, von Bergwelt-Baildon MS (2018) Cytokine release syndrome. J Immunother Cancer 6(1):56–56. https://doi.org/10.1186/s40425-018-0343-9

    Article  PubMed  PubMed Central  Google Scholar 

  • Tian S, Hu W, Niu L, Liu H, Xu H, Xiao S-Y (2020) Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol

    Google Scholar 

  • van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ (2020) Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. https://doi.org/10.1056/NEJMc2004973

  • Walle LV, Lamkanfi M (2016) Pyroptosis. Curr Biol 26(13):R568–R572

    Article  Google Scholar 

  • Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y (2020a) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama

    Google Scholar 

  • Wang H, Luo S, Shen Y, Li M, Zhang Z, Dong Y, Zhou H, Lin L, Guo W, Kang Z (2020b) Multiple enzyme release, inflammation storm and hypercoagulability are prominent indicators for disease progression in COVID-19: a multi-centered, correlation study with CT imaging score

    Google Scholar 

  • Wang W, He J, Wu S (2020c) The definition and risks of cytokine release syndrome-like in 11 COVID-19-infected pneumonia critically ill patients: disease characteristics and retrospective analysis. medRxiv

    Google Scholar 

  • World Health Organization (2020) Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, March 2 2020. World Health Organization.

    Google Scholar 

  • Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. Jama

    Google Scholar 

  • Xing Z, Afkhami S, Bavananthasivam J, Fritz DK, D’Agostino MR, Vaseghi-Shanjani M, Yao Y, Jeyanathan M (2020) Innate immune memory of tissue-resident macrophages and trained innate immunity: re-vamping vaccine concept and strategies. J Leukoc Biol

    Google Scholar 

  • Xiong Y, Liu Y, Cao L, Wang D, Guo M, Guo D, Hu W, Yang J, Tang Z, Zhang Q (2020) Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Available at SSRN 3549993

    Google Scholar 

  • Xu H, Hou K, Xu H, Li Z, Chen H, Zhang N, Xu R, Fu H, Sun R, Wen L (2020a) Acute myocardial injury of patients with coronavirus disease 2019. medRxiv

    Google Scholar 

  • Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L (2020b) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med

    Google Scholar 

  • Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T (2020a) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med

    Google Scholar 

  • Yang Y, Shen C, Li J, Yuan J, Yang M, Wang F, Li G, Li Y, Xing L, Peng L (2020b) Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome. medRxiv

    Google Scholar 

  • Yazdanpanah F, Hamblin MR, Rezaei N (2020a) The immune system and COVID-19: friend or foe? Life Sci 256:117900. https://doi.org/10.1016/j.lfs.2020.117900

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yazdanpanah N, Saghazadeh A, Rezaei N (2020b) Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19). Rev Neurosci. https://doi.org/10.1515/revneuro-2020-0039

  • Yousefzadegan S, Rezaei N (2020) Case Report: death due to COVID-19 in Three Brothers. Am J Trop Med Hyg 102(6):1203–1204. https://doi.org/10.4269/ajtmh.20-0240

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhang D, Guo R, Lei L, Liu H, Wang Y, Wang Y, Dai T, Zhang T, Lai Y, Wang J (2020a) COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome. medRxiv

    Google Scholar 

  • Zhang L, Shen FM, Chen F, Lin Z (2020b) Origin and evolution of the 2019 novel coronavirus. Clin Infect Dis

    Google Scholar 

  • Zhang L, Yang J-R, Zhang Z, Lin Z (2020c) Genomic variations of COVID-19 suggest multiple outbreak sources of transmission. medRxiv

    Google Scholar 

  • Zhang W, Du R-H, Li B, Zheng X-S, Yang X-L, Hu B, Wang Y-Y, Xiao G-F, Yan B, Shi Z-L (2020d) Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 9(1):386–389

    Article  CAS  Google Scholar 

  • Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Sun R, Tian Z, Xu X, Wei H (2020) Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients. Natl Sci Rev

    Google Scholar 

  • Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J (2020) SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 382(12):1177–1179

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Center for Immunodeficiencies, Children’s Medical Center Hospital, Tehran University of Medical Sciences, Tehran, Iran

    Amene Saghazadeh & Nima Rezaei

  2. Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran

    Amene Saghazadeh

  3. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

    Nima Rezaei

  4. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

    Nima Rezaei

Authors
  1. Amene Saghazadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nima Rezaei
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nima Rezaei .

Editor information

Editors and Affiliations

  1. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran

    Nima Rezaei

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Saghazadeh, A., Rezaei, N. (2021). How COVID-19 Has Globalized: Unknown Origin, Rapid Transmission, and the Immune System Nourishment. In: Rezaei, N. (eds) Coronavirus Disease - COVID-19. Advances in Experimental Medicine and Biology, vol 1318. Springer, Cham. https://doi.org/10.1007/978-3-030-63761-3_8

Download citation

Publish with us

Policies and ethics

Search

Navigation